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Aqueous syntheses of [(Cp-R)M(CO)3] type complexes (Cp =
cyclopentadienyl, M = Mn, 99mTc, Re) with bioactive
functionalities
Abstract
We describe reactions of [99mTc(H2O)3(CO)3)]+ (1) with Diels-Alder products of cyclopentadiene
such as “Thiele's acid” (HCp-COOH)2 (2) and derivatives thereof in which the corresponding
[(Cp-COOH)99mTc(CO)3)] (3) complex did form in water. We propose a metal mediated Diels-Alder
reaction mechanism. To show that this reaction was not limited to carboxylate groups, we synthesized
conjugates of 2 (HCp-CONHR)2 (4a-c) (4a, R = benzyl amine; 4b, R = Nα-Boc-l-2,3-diaminopropionic
acid and 4c, R = glycine). The corresponding 99mTc complexes [(4a)99mTc(CO)3)] 6a,
[(4b)99mTc(CO)3)] 6b and [(4c)99mTc(CO)3)] 6c have been prepared along the same route as for
Thiele's acid in aqueous media demonstrating the general applicability of this synthetic strategy. The
authenticity of the 99mTc complexes on the no carrier added level have been confirmed by
chromatographic comparison with the structurally characterized manganese or rhenium complexes.
Studies of the reaction of 1 with Thiele's acid bound to a solid phase resin demonstrated the formation of
[(Cp-COOH)99mTc(CO)3)] 3 in a heterogeneous reaction. This is the first evidence for the formation of
no carrier added 99mTc radiopharmaceuticals containing cyclopentadienyl ligands via solid phase
syntheses. Macroscopically, the manganese analogue 5a and the rhenium complexes 5b-c have been
prepared and characterized by IR, NMR, ESI-MS and X-ray crystallography for 5a (monoclinic, P21/c,
a = 9.8696(2) Å, b = 25.8533(4) Å, c = 11.8414(2) Å, β = 98.7322(17)°) in order to unambiguously
assign the authenticity of the corresponding 99mTc complexes.
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Abstract  
 
We describe reactions of [99mTc(H2O)3(CO)3)]+ 1 with Diels-Alder products of 
cyclopentadiene such as “Thiele´s acid” (HCp-COOH)2 2 and derivatives thereof in which the 
corresponding [(Cp-COOH)99mTc(CO)3)] 3 complex did form in water. We propose a metal-
mediated Diels-Alder reaction mechanism. To show that this reaction was not limited to 
carboxylate groups, we synthesized conjugates of 2 (HCp-CONHR)2 4a-c (4a, R = benzyl 
amine; 4b, R = Nα-Boc-L-2,3-diaminopropionic acid and 4c, R = glycine). The corresponding 
99mTc complexes [(4a)99mTc(CO)3)] 6a, [(4b)99mTc(CO)3)] 6b and [(4c)99mTc(CO)3)] 6c have 
been prepared along the same route as for Thiele’s acid in aqueous media demonstrating the 
general applicability of this synthetic strategy. The authenticity of the 99mTc complexes on the 
no carrier added level have been confirmed by chromatographic comparison with the 
structurally characterized manganese or rhenium complexes. 
Studies of the reaction of 1 with Thiele´s acid bound to a solid phase resin demonstrated the 
formation of [(Cp-COOH)99mTc(CO)3)] 3 in a heterogeneous reaction. This is the first 
evidence for the formation of no carrier added 99mTc radiopharmaceuticals containing 
cyclopentadienyl ligands via solid phase syntheses. Macroscopically, the manganese analogue 
5a and the rhenium complexes 5b-c have been prepared and characterized by IR, NMR, ESI-
MS and X-ray crystallography for 5a (monoclinic, P21/c, a = 9.8696(2) Å, b = 25.8533(4) Å, 
c = 11.8414(2) Å, = 98.7322(17)°) in order to unambiguously assign the authenticity of the 
corresponding 99mTc complexes.  
 
 
 
 2
1. Introduction 
The group 7 transition metals Tc and Re are in the main focus for novel radiopharmaceuticals 
in diagnostic imaging (99mTc) or for therapeutic (186Re, 188Re) purposes [1-4]. Organometallic 
compounds are generally considered to require water and air free synthetic conditions and to 
be therefore not compatible with biomedical applications. However, the preparation of the 
complex [99mTc(CN-R)6]+ directly from [99mTcO4]- in water clearly eliminated this prejudice 
[5]. This complex contained monodentate ligands only but is still perfectly stable under in 
vivo conditions due to the kinetic stability of the d6 electronic configuration. This isocyanide 
99mTc complex is the most widely used radiopharmaceutical in myocardial imaging [6]. 
Chemically, its high stability towards substitution reactions makes it not suitable for the so 
called third generation radiopharmaceuticals, labeled targeting biomolecules. On the other 
hand, the need for innovative and efficient synthetic methods of organometallic compounds 
from water is crucial for application in the bio-organometallic field[7,8]. 
Cyclopentadienyl (Cp-) is one of the most basic ligand in organometallic chemistry. 
Cyclopentadienyl is relevant since it has a low molecular weight, it blocks three coordination 
sites and includes the possibility of conjugating targeting vectors. Keeping the principle of 
using inert complexes for radiopharmaceutical in vivo applications in mind, Cp- forms robust 
organometallic [(Cp-R)M(CO)3] (M = Re, Tc) complexes with Tc and Re being in the 
oxidations state +1. In fact, complexes [(Cp-R)M(CO)3] have been attached both to 
antibodies[9,10] and to steroidal hormones[11,12] without substantial loss of receptor 
recognition and affinity. A more prominent and well explored example is in the context of 
tamoxifen / ferrocifen where [CpRe(CO)3] was shown to surrogate ferrocene under retention 
of biological activity [13,14]. Cyclopentadienyl on other hand has severe disadvantages for 
applications in water. It is essentially insoluble and unstable in water, tends to di- or 
polymerize and can hardly be deprotonated (pKa ≈ 15). For radiopharmaceutical applications 
on a routine base, it is desirable to prepare e.g. [(Cp-R)99mTc(CO)3] directly in water. Some 
approaches to [Cp-R99mTc(CO)3] have been reported but most of them require harsh condition 
and organic solvents [15-18]. We reported a fully aqueous synthesis of [(Cp-R)99mTc(CO)3] at 
< 100°C [19]. Still, the drawback of this approach was the sensitivity of Cp group pendent to 
the biomolecule. To circumvent this issue, protection of the Cp- ligand would be helpful. The 
Diels-Alder product of dimerized [HCp-R] would be an ideal precursor provided that it could 
be concertedly cleaved and coordinated. We recently showed that the reaction of 
[99mTc(H2O)3(CO)3)]+ 1 with Diels-Alder products such as Thiele´s acid (HCp-COOH)2 2 
gave the corresponding [(Cp-COOH) 99mTc(CO)3)] 3 complex. The labelling conditions were 
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such that 2 did not thermally cleave [20]. Hence, we proposed that the retro Diels-Alder 
reaction with concerted coordination to the [99mTc(CO)3]+ core was metal-mediated. A first 
step might involve the coordination of the carboxylate followed by cleavage and coordination. 
Dimerized cyclopentadiene compounds can therefore be considered as “pre-cyclopentadiene” 
able to form the {(η5-Cp)Tc} core.  
As an important extension to the previous synthetic approaches, we describe inhere a more 
general approach to [(Cp-R)99mTc(CO)3] complexes which also allows the introduction of 
additional functionalities R on the Cp ring. Thiele´s acid was coupled with amines to give 
amides. We show that amides can also act as anchoring group and the corresponding 99mTc 
complexes be synthesized along a retro Diels-Alder reaction. The scope of this finding is the 
principal possibility of coupling different families of biomolecules, including peptides or 
other small amine containing vectors to the cyclopentadiene ring. Furthermore, we will show 
that the retro Diels-Alder can also be performed directly on a solid phase support. Thereby, 
the synthesis of no carrier added [(Cp-R)99mTc(CO)3] type complexes is enabled.  
 
2. Results and Discussion 
 
2.1. Synthesis of ligands  
Thiele’s acid is a very convenient precursor for the preparation of cyclopentadiene 
derivatives. Starting from [HCp-COOH], Diels-Alder dimerisation gave different 
stereoisomers[21]. One of the isomers could be separated by fractioned crystallization and its 
structure being elucidated. An ORTEP together with important bond lengths and angles is 
given in figure 1. All subsequent functionalisations were then performed with this single 
isomer (scheme 1). The preparation of ligand 4a (HCp-ba)2 and 4b (HCp-dap)2 was 
performed in a two step reaction. Thiele´s acid was easily activated with pentafluorophenyl-
trifluoroacetate in an N,N-dimethylformamide (DMF) / pyridine mixture at room temperature 
to yield 4 in quantitative yield in solution [22]. Precursor 4 was then allowed to react with 
benzyl amine to yield 4a in 43% yield as white solid. Using the same protocol, Nα-Boc-L-2,3-
diaminopropionic acid (Boc = tert-butoxycarbonyl) was reacted with 4 and the reaction was 
monitored by HPLC. Deprotection with a trifluoroacetic acid (TFA) / CH2Cl2 mixture 1:1 
gave 4b in 95 % yield as an off-white solid. The analytical data (see experimental part) 
confirmed the authenticity of the compounds. The synthesis of 4c (HCp-gly)2 was previously 
reported by us [20]. We would like to emphasize at this point, that this strategy can be 
followed by principally any biomolecule. Along this route, targeting vectors such as peptides 
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or CNS receptor ligands can be introduced. Taking the clean labelling with 99mTc into account 
(vide infra) it became clear that new labelled biomolecules can be introduced in which the 
amide functionality acts as an anchoring and activation group for the formation of [(Cp-
R)99mTc(CO)3] complexes. 
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Scheme 1. Syntheses of the activated form of Thiele’s acid 4, and amide derivatives 4a – 4c 
containing a benzyl group, an amino acid and glycine. 
 
 
 
Figure 1. ORTEP presentation of Thiele’s acid dimethyl ester. Important bond lengths (Å) 
and angles (°) are: C(2)-C(6) = 1.3374(19); C(12)-C(16) = 1.5009(18); C(12)-C(13) = 
1.3343(17); C(13)-C(14) = 1.4947(17); C(6)-C(2)-C(1) = 124.76(12); C(6)-C(2)-C(3) = 
107.74(11); C(13)-C(12)-C(11) = 126.00(12); C(13)-C(12)-C(16) = 113.05(11); C(12)-C(13)-
C(14) = 112.40(11). 
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 2.2. Synthesis of manganese and rhenium complexes 
A comparison of the HPLC retention times of the fully characterized manganese, rhenium or 
technetium complexes with the corresponding 99mTc compounds is an accepted method to 
assess the authenticity of the 99mTc complexes. Accordingly, the manganese complex [(Cp-
ba)Mn(CO)3] 5a and the rhenium complexes [(Cp-dap)Re(CO)3] 5b and [(Cp-gly)Re(CO)3] 
5c were synthesized by different methods and fully characterized with spectroscopic methods 
including X-ray crystallography for 5a (scheme 2). As described above for the free ligands, 
the complexes 5a-c were synthesized by activation of cymantrene-carboxylic acid [(Cp-
COOH)Mn(CO)3] or its rhenium analogue with penta-fluorophenyl-trifluoroacetate[22] in the 
presence of pyridine. These activated complexes were then allowed to react with benzylamine 
to give 5a as a yellow powder in 65% yield. Compound 5a could be recrystallised from 
CH2Cl2 / hexane to afford X-ray quality crystals. The proton NMR of 5a in CDCl3 showed the 
aromatic protons at 7.25 ppm as multiplet and the protons of the cyclopentadienyl ring were 
observed at 5.23 and 4.70 ppm respectively as two distinct multiplets. The NH amide proton 
and the methylene proton are observed at 5.91 and 4.31 ppm as two broad signals. The 
infrared spectrum in KBr showed the two characteristic strong bands for νCO at 2028 and 1927 
cm-1 respectively which confirmed the presence of the fac-[Mn(CO)3]+ moiety. The amide 
C=O bond stretch showed a strong absorption at 1638 cm-1. Furthermore, the ESI-MS in both, 
positive and negative mode showed single peaks at 360 and 336 corresponding to M+Na 
respectively M-H. 5b was prepared using the same protocol with [(Cp-COOH)Re(CO)3] and 
Nα-Boc-L-2,3-diaminopropionic acid followed by TFA deprotection. After workup 5b was 
isolated as TFA salt giving a yield of 70% with respect to the starting material [(Cp-
COOH)Re(CO)3]. The ESI-MS positive mode measurements realized in methanol, indicated a 
peak at 467 as a main peak corresponding to M+H. As expected, the IR spectrum displays two 
strong vibration νCO at 2026 and 1926 cm-1 associated to fac-[Re(CO)3]+ fragment and one 
amide C=O bond stretch at 1639 cm-1. The proton NMR spectrum in CD3OD confirmed the 
proposed structure with the presence of two triplets associated to Cp ring at 6.16 and 5.59 
ppm while the α proton to amino acid function and the CH2 appear as two multiplets at 3.75 
and 3.68 ppm. 
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Scheme 2. Syntheses of the manganese and rhenium complexes 5a-c. 
 
Crystals suitable for an x-ray structure analysis were obtained for cymantrene functionalized 
with benzyl amine 5a by recrystallization from CH2Cl2 / hexane. An ORTEP is given in 
figure 2. The compound crystallizes in the monoclinic crystal system (Table 1). The 
manganese central atom is η5-coordinated to the C5H4-CO-NH-CH2-C6H5 ligand and the three 
CO groups complete the coordination sphere. The geometry around manganese is pseudo 
octahedral and, accordingly, C-M-C between CO are close to 90°. The amide group O4-C9-
N1 has the usual geometrical parameters with a C-N bond length of 1.339(2) Å and is 
essentially in the same plane with the neighboring cyclopentadienyl ring (1.2° torsion angle 
between the amide group and the Cp plane). This lead to orthogonal orientation between the 
Cp and the phenyl ring. All the geometrical parameters agreed well with the data reported for 
(C5H4COCH3)Mn(CO)3 in the literature[23]. 
 
 
 
Figure 2. ORTEP presentation of [(Cp-ba)Mn(CO)3] 5a. Important bond lengths (Å) and 
angles (°) are: Mn(1)-C(1) = 1.7905(16); Mn(1)-C(3) = 1.796(2); Mn(1)-C(2) = 1.7996(17); 
Mn(1)-C(4) = 2.1210(15); Mn(1)-C(5) = 2.1363(16); C(9)-N(1) = 1.339(2); C(10)-N(1) = 
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1.452(2); C(1)-O(1) = 1.1414(19); C(2)-O(2) = 1.1423(19); C(4)-C(8) = 1.428(2); C(4)-C(5) 
= 1.430(2); C(1)-Mn(1)-C(3) = 92.11(8); C(1)-Mn(1)-C(2) = 92.47(7); C(2)-Mn(1)-C(3) = 
92.26(8); C(1)-Mn(1)-C(4) = 99.81(7); O(1)-C(1)-Mn(1) = 178.07(15); O(2)-C(2)-Mn(1) = 
178.72(15). 
 
Table 1. Crystallography parameters for complex 5a and Thiele’s dimethyl ester 
Formula C16H12MnNO4 C14H16O4 
M (g mol-1) 337.21 248.27 
Crystal system Monoclinic Monoclinic  
Space group P21/c P21/n 
a(Å)  9.8696(2) 8.0642(2) 
b(Å)  25.8533(4) 6.0850(1) 
c(Å) 11.8414(2) 24.9771(5) 
β(°) 98.7322(17) 94.453(2) 
V(Å3) 2986.45(9) 1221.94(4) 
Z 8 4 
Dc calc (g.cm-3) 1.500 1.350 
Linear absorption coefficient (mm-1) 0.900 0.099 
Absorption correction multi-scan multi-scan 
Rel. transmin/transmax 0.88553/1.00000 0.91246/1.00000 
Measured reflections 38865 13181 
Unique reflections/Rint 9105/0.0387 3734/0.0242 
Refined parameters 397 165 
R1(F) / wR2 (F2) (I>2σ(I))a 0.0347/0.0835 0.0480/0.1230 
GooF 0.953 1.057 
 
a R1 = |Fo - Fc|/|Fo|; wR2 = [w(Fo2 – Fc2)2/ (wFo2)]-1/2. 
 
2.3. Syntheses of 99mTc complexes 
We recently reported the metal mediated retro Diels-Alder reaction of (HCp-COOH)2 with 
[99mTc(OH2)3(CO)3]+ or [99mTcO4]- under formation of the corresponding cyclopentadienyl 
complex [(Cp-COOH) 99mTc(CO)3] 3 [20,24]. On the basis of these results, we investigated 
the possibility of extending this method to retro Diels-Alder reactions with building blocks 
different from 2. We were especially interested in other functionalities, particularly amide 
groups, bound to the cyclopentadiene ring. Although this has principally been shown with 
ligand 4c, the presence of the carboxylate group in this ligand might still be the anchoring 
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group required for cyclopentadienyl complex formation. In ligand 4a, this was not the case 
anymore. Thus, if 4a could be labelled, a clear hint was given that a carboxylate group is not 
an absolute requirement for retro Diels-Alder reaction. This should lead to a more general 
approach towards [(Cp-R)99mTc(CO)3] complexes conjugated to targeting molecules. 
Complexes 5a-c are the models based on which the identity of the corresponding 99mTc 
complexes can be confirmed.  
We used three different procedures to synthesize the 99mTc complexes 6a – 6c. In particular, 
pH, reaction time and temperature were varied in order to find optimal conditions for the 
metal mediated retro Diels-Alder reaction. Method A involved the classical “one pot” reaction 
which was the direct synthesis from [99mTcO4]- in an Isolink® Kit and in the presence of 
ligands 4a-c. Method B was a two step procedure under alkaline conditions, thereby 
[99mTc(OH2)3(CO)3]+ was synthesized first and then reacted with the corresponding ligand. 
Method C finally consisted also in a two step reaction, initial synthesis of 1, neutralizing the 
solution with phosphate buffer to pH = 7.4 and subsequent addition and reaction with 4a–c. 
The reactions and the corresponding products are depicted in scheme 3. 
 
 
 
Scheme 3. Preparation of the 99mTc complexes 6a-c under aqueous conditions. 
 
The compounds (HCp-CONHR)2 4a-b were reacted directly with [99mTcO4]- in the presence 
of boranocarbonate [H3BCOOH]- to give 6a-b after 30-180 min at 95°C in quantitative yield. 
In the reaction solutions, we could not detect measurable amounts of the respective monomers 
of 4a or 4b by HPLC. Still, for all reactions, one HCp-R per 99mTc must be released. Since the 
concentration of [99mTcO4]- is very low (10-8-10-7 M) we did not expect to find the monomer 
provided that no thermal retro Diels-Alder reaction occurred, which was obviously not 
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[25]the case. Decreasing the temperature to 70°C reduced the rate of the reaction and we 
started to observe the formation of side products especially for 4b. Since no corresponding 
model compounds could be used to identify the composition of these side products, we 
assume that under more moderate conditions coordination might also take place at the amino 
acid part in 4b. Though not a very favorable bidentate ligand, we showed previously that 
coordination takes place under formation of well defined amino acid complexes[20]. Unlike 
of basic direct synthesis of 6a and 6c, the preparation of 6b is best realized with the buffered 
method which gave quantitative conversion. The pH of the reaction seemed of to be crucial 
for the metal mediated retro Diels-Alder reaction especially for the zwitterions of amino acid 
derivatives. The authenticity of the 99mTc compounds could be assessed by comparison with 
the cold manganese and rhenium analogues synthesized before. An example for an HPLC 
comparison is given in figure 3. The inverted trace on top shows the radiochromatogram of 6a 
whereas the lower one gives the UV/vis absorption trace of the manganese surrogate 5a. 
 
 
Figure 3. HPLC trace of the cold manganese complex 5a and the corresponding 99mTc 
complex 6a complex as prepared directly from [99mTcO4]-. The time difference is due to 
detector separation. 
 
2.4. Retro Diels-Alder reaction on a solid phase  
The Diels-Alder product of Thiele´s acid (HCp-COOH)2 2 was chosen as a model substrate to 
investigate if the corresponding complexes [(Cp-COOH)99mTc(CO)3] could be synthesized 
directly on solid phase support. This would give access to no carrier added 99mTc complexes. 
A low concentration of radiopharmaceutical is crucial in application when working with 
receptor targeting agents. A too high concentration of e.g. unlabelled peptide would avoid 
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good images since the cold peptides preferentially bind to the receptors. Thus, reasonable 
images could not be received due to insufficient target to background ratio. The solid phase 
polymer was a polystyrene matrix functionalized with polyethyleneglycol and bearing 
terminal NH2 groups. These polymers had good swelling properties in water. The polymer 
was then linked via an amide bond to 2 previously activated with the O-(7-Azabenzotriazol-1-
yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU) / N,N-
diisopropylethylamine procedure. The efficiency of the coupling reaction was performed 
according to literature procedure with a 2,4,6-trinitrobenzylsulfonic acid (TNBS) test. This 
allowed a semi-quantitative analysis of the uncoupled terminal amino groups [26]. Essentially 
no free NH2 groups were detected by this method, thus, confirming the complete 
derivatization of the resin by Thiele’s acid. The procedure and the products are shown in 
scheme 4. Additional IR spectroscopy analysis in KBr pellets showed the presence of two 
news peaks at 1535 and 1712 cm-1 respectively. Since these bands were not present in the 
unmodified resin, we attributed them to the amide bond and the terminal carboxylic group of 
coupled Thiele´s acid. 
 
 
Scheme 4. Solid phase synthesis and labeling of Thiele´s acid. 
 
The resulting polymer 7, Thiele´s acid PEG-NH-CO-(HCp)2COOH derivative was first 
swelled in water at 4°C for 3 h and then allowed to react in one pot reaction in presence of 
[99mTcO4]- and [H3BCOOH]- at 95°C for 3h (scheme 4). The reaction mixture was then cooled 
and the solid phase removed by filtration. The HPLC analysis of the remaining solution 
revealed one single peak at 21.35 min and residual [99mTcO4]-. the formation of [(Cp-
COOH)99mTc(CO)3] 3 at 21.35 min in 50% yield in the reaction mixture. This is to our 
knowledge, the first evidence of aqua metal mediated retro Diels-Alder on solid support. 
Even though the reaction occurred in basic condition with [99mTc(H2O)3(CO)3] 1, the 
modulation of other parameters such reaction time and temperature did not improved the yield 
but we observed the rising of additional peaks. It seems that [99mTcO4]- or 1 could not reach 
efficiently the polymer bound Thiele´s acid in heterogeneous conditions since it is reasonable 
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to assume that the distribution of polymer is not homogeneous in the vial. However, 3 could 
be easily assigned by direct synthesis from Thiele´s acid and 1 in water buffer with almost 
quantitative conversion as previously described[20].  
 
 
3. Conclusion  
Thiele´s acid has been conjugated to different functional groups. These dimers ligands were 
found to be compatible to generated piano stool-like 99mTc complexes in water. Metal 
mediated retro Diels-Alder seems to be a new general approach to produce biomolecules 
[(Cp-R)99mTc(CO)3] with more complex functionalities bound to cyclopentadienyl. 
Furthermore, promising preliminary studies shown that the scope of this retro Diels-Alder 
reaction can be extend to the solid phase synthesis in aqueous media. This water solid phase 
synthesis of 99mTc complexes is to our knowledge, the first evidence of metal mediated retro 
Diels-Alder on solid support. 
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4. Experimental Section. 
 
General remarks. Reactions were carried out in oven-dried Schlenk glassware under an 
atmosphere of pure nitrogen when necessary. Solvents were dried over molecular sieves and 
degassed prior to use. All chemicals were obtained from commercial sources and used 
without further purification. The acid [(Cp-COOH)M(CO)3] (M = Mn, Re) and 5c were 
prepared according to literature procedure. [20, 21] NMR spectra were recorded on Bruker 
Advance 500, 400 and Varian 200 spectrometers. Chemical shifts  in ppm relative to 
tetramethylsilane (TMS) and coupling constants J are given in Hz. Mass spectra were 
measured on Bruker Esquire HCT (ESI) instrument, only characteristic fragments are given. 
The solvent flow rate for ESI measurements was 5 l·min-1 with a nebulizer pressure of 15 psi 
and a dry gas flow rate of 5 l·min-1 at a dry gas temperature of 300 °C. IR spectra were 
recorded as KBr pellets on a Perkin Elmer BX II IR spectrometer.  
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HPLC solvents consisted of 0.1% CF3COOH in H2O (solvent A) and methanol (solvent B) 
with variable gradient (0-3 min, 100% A; 3-3.1 min, 0 to 25% B; 3.1-9 min, 25% B; 9-9.1 
min, 25% B to 34% B; 9.1-20 min, 34% B to 100% B; 20-25 min, 100% B; 25-25.1 min 
100% B to 100% A; 25.1-30 min 100% A).  
 
4.1. bis(pentafluorophenyl) 3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-2,6-dicarboxylate 4 
3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-2,6-dicarboxylic acid (Thiele’s acid) 2 (881 mg, 
4.0 mmol) was dissolved in 9 ml of DMF. Pyridine (708 µl, 8.8 mmol) and penta-
fluorophenyl trifluoroacetate (1.6 ml, 9.3 mmol) were added, and the solution stirred at r.t. 
under N2 for 5 h. 600 ml ethyl acetate were added, and the solution washed three times with 
0.1 N HCl and once with 5% (wt/vol) aqueous NaHCO3. The organic phase was dried over 
Na2SO4 and the solvent removed in vacuo to produce 2.346 g of crude product which 
contained approximately 20% of mono-activated product. The solid was then dissolved in 200 
ml of CH2Cl2 and extracted with 400 ml of 5% Na2HCO3. The organic phase was dried under 
reduced pressure and 1.639 g (74% yield) of 4 was isolated as a brownish oil. The product 
was used for the next synthesis step without further purification. 
1H NMR (400 MHz, CDCl3): δ 7.28 (d, 1H, J = 3.2 Hz, CH), 6.88 (d, 1H, J = 2.1 Hz, CH), 
3.71 (m, 1H, CH), 3.53 (m, 1H, CH), 3.35 (m, 1H), 3.12 (m, 1H, CH), 2.68 (m, 1H, CH), 2.25 
(m, 1H, CH), 1.86 (m, 1H, CH), 1.55 (m, 1H, CH). 19F{1H} NMR (CDCl3): δ-154.6, -159.8, -
164.0.  
 
4.2. N,N'-dibenzyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoindene-2,6-dicarboxamide 4a 
Compound 4 (811 mg, 1.47 mmol) was dissolved in 15 ml (DMF) and stirred under N2 at 
0°C. A solution of benzyl amine (376 mg, 3.52 mmol) and NaHCO3 (296 mg, 3.52 mmol) in 
15 ml water was added drop-wise via syringe through a rubber seal cap. The reaction mixture 
was stirred under N2at 0°C for 10 h. The solvent was then removed under reduced pressure 
and the residue dissolved in 150 ml H2O and acidified with 1N HCl to pH 3. The solution was 
extracted three times with 150 ml of CH2Cl2. After each extraction step the pH of the aqueous 
phase was re-adjusted to 2–3. The combined organic phases were dried over Na2SO4. The 
solvent was removed in vacuo and the crude product purified by flash chromatography with a 
gradient from pure CH2Cl2 to CH2Cl2 / MeOH 1:1. 4a was isolated as white powder (266 mg, 
43% yield). Calcd. for Mr (C26H26N2O2) 398.5; ESI-MS(CH3OH, pos. Mode): 421.3 
[M+Na]+; calc. C, 78.36; H, 6.58; N, 7.03; Found: C, 78.30; H, 6.74; N, 6.92. 1H NMR (200 
MHz, CDCl3),  7.29-7.32 (m, 10H, Ph), 6.43 (d, 1H, J = 3.2 Hz, CH), 6.15 (d, 1H, J = 2.8 
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Hz, CH), 5.75-5.86 (m, 2H, NH), 4.35-4.52 (m, 4H, CH2), 3.65 (m, 1H, CH), 3.43 (m, 1H, 
CH), 3.06 (m, 1H, CH), 2.96 (m, 1H, CH), 2.01-2.43 (m, 2H, CH2), 1.45-1.67 (2H, CH2) 
 
4.3. 3,3'-[tricyclo[5.2.1.02,6]deca-3,8-diene-4,8-diylbis(carbonylimino)]bis(2-aminopropanoic 
acid) 4b 
Compound 4 (1.620 g, 2.93 mmol) was dissolved in 33 ml DMF and stirred under N2 at 0°C. 
A solution of Nα-Boc-L-2,3-diaminopropionic acid (Boc-Dap-OH) (1.438 g, 7.04 mmol) and 
NaHCO3 (591 mg, 7.04 mmol) in 33 ml H2O was added drop-wise via syringe. The reaction 
mixture was stirred under N2 at 0°C during 10 h. The solvent was removed and the residue 
dissolved in 300 ml H2O and acidified with 1N HCl to pH 3. The solution was extracted 3x 
with 300 ml CH2Cl2. After each extraction step the pH of the aqueous phase was re-adjusted 
to 2 –3. The combined organic phases were dried over Na2SO4. The crude product was 
purified by flash chromatography as for 4a. The product (1.020 g, 59% yield) was obtained as 
an off-white powder. For deprotection, 103 mg (0.17 mmol) was dissolved in 2 ml of a 1:1 
(v/v) mixture of F3CCOOH and CH2Cl2. After stirring for 4 h at r.t. under N2, the solution 
was cooled to 0°C and 2 ml of H3CCN were added, followed by solvent removal in vacuo. 
This procedure was repeated twice. The dry residue was dissolved in 8 ml 1N HCl and 
lyophilized, resulting in 100 mg (95% yield) 4b as a slightly brown solid. Calcd. for Mr 
(C18H24N4O6) 392.41; ESI-MS(CH3OH, neg. Mode): 391.1 [M-H]-; 1H NMR (500 MHz, 
D2O): 6.84 (m, 1H, CH), 6.48 (m, 1H, CH), 4.28-4.16 (m, 2H, CH2), 3.90-3.72 (m, 4H, 
CH2), 3.68-3.59 (m, 1H, CH), 3.38-3.31 (m, 1H, CH), 3.29-3.22 (m, 1H, CH), 3.12-3.02 (m, 
1H, CH), 2.58-2.47 (m, 1H, CH), 2.01-1.83 (m, 1H, CH), 1.73-1.66 (m, 1H, CH), 1.53-1.46 
(m, 1H, CH). 
 
4.4. Synthesis of [(CpCONHCH2C6H5)Mn(CO)3] 5a 
Cymantrene carboxylic acid (248 mg, 1 mmol) was dissolved in 1 ml of dry DMF. Pyridine 
(81 µl, 0.853 mmol) and pentafluorophenyl trifluoroacetate (PFT, 174 µl, 1.0 mmol) were 
added and the solution was stirred for 3 h under N2 at r.t. The reaction mixture was diluted 
with 30 ml ethyl acetate and washed 3x with 30 ml of 0.1 M HCl and once with 30 ml of 5% 
NaHCO3. The organic phase was dried over Na2SO4 the solvent removed under reduced 
pressure and the yellow solid 3 (350 mg, 85% yield) was used without further purification. 
(207 mg, 0.5 mmol) of activated cymantrene carboxylic acid 3 was dissolved in 8.5 ml of 
DMF and stirred under N2 at 0°C. A solution of benzyl amine (53 mg, 0.5 mmol) and 
NaHCO3 (66 mg, 0.78 mmol) in 8.5 ml of H2O was added via syringe. The reaction mixture 
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was stirred under N2 at 0°C for 4 h . After solvent removal, the residue was dissolved in 50 ml 
of CH2Cl2 and washed with 50 ml of 1 mM HCl. A small amount of 0.1 M HCl was added 
during extraction to ensure a final pH of 3 in the aqueous phase which was then extracted 3x 
with 150 ml of CH2Cl2. The combined organic phases were dried over Na2SO4. The crude 
product was purified by flash chromatography, using a gradient from CH2Cl2 to CH2Cl2 / 
MeOH 5:1. The product (396 mg, 65% yield) was obtained as a slightly yellow powder which 
could be recrystallised from CH2Cl2 / hexane mixture. Calcd. for Mr (C16H12MnNO4) 337.21; 
ESI-MS (CH3OH, pos. Mode): 360.0 [M+Na]+, ESI-MS (CH3OH, neg. Mode): 336.0 [M-H]-; 
calc. C, 56.99; H, 3.59; N, 4.15; Found: C, 56.81; H, 3.63; N, 4.16. 1H NMR (500 Mz, 
CDCl3): δ 7.25 (m, 5H, Ph), 5.91 (m, 1H, NH), 5.23 (m, 2H, Cp), 4.70 (m, 2H; Cp), 4.31 (m, 
2H, CH2); 13C{1H} NMR (125 MHz, CDCl3): δ 223.90, 138.25 (1C, Ph), 129.34 (1C, Ph), 
128.38 (1C, Ph), 128.26 (1C, Ph), 91.13 (1C, Cp), 85.12 (1C, Cp), 83.41 (1C, Cp), 44.36 (1C, 
CH2); IR (KBr): 3300, 2028, 1927, 1638, 1560 cm-1. 
 
4.5 Synthesis of [(CpCOOC6F5)Re(CO)3] 3´ 
[(Cp-COOH)Re(CO)3] (274 mg, 0.775 mmol) was dissolved in 1 ml of dry DMF. Pyridine 
(69 µl, 0.853 mmol) and PFT (155 µl, 0.900 mmol) were added and the solution was stirred 
for 3 h under N2 at r.t. The reaction mixture was diluted with 75 ml ethyl acetate and washed 
three times with 75 ml of 0.1 M HCl and then with 75 ml of 5% NaHCO3. The organic phase 
was dried with Na2SO4 and the solvent was removed in vacuo to yield 344 mg (81%) of 3´. 
1H NMR (200 MHz; acetone-d6): δ 6.55 (t, 2H, J = 2.4 Hz, Cp), 5.89 (t, 2H, J = 2.4 Hz, Cp); 
19F{1H} NMR (acetone-d6): δ-155.0, -159, 164.5. 
 
4.6. Synthesis of [Re(CO)3(CpCONHCH2CH(NH3)COOH)](CF3COO) 5b 
Compound 3´ (711 mg, 1.30 mmol) was dissolved in 8.5 ml of DMF and stirred under N2 at 
0°C. A solution of Nα-Boc-L-2,3-diaminopropionic acid (Boc-Dap-OH) (319 mg, 1.56 mmol) 
and NaHCO3 (132 mg, 1.56 mmol) in 8.5 ml of water was added dropwise via syringe. The 
reaction mixture was stirred under N2 at 0°C for 4 h, the solvent removed in vacuo and the 
residue dissolved in 150 ml of CH2Cl2 and washed with 150 ml of 1 mM HCl. A small 
amount of 0.1 M HCl was added during extraction to ensure a final pH of 3 in the aqueous 
phase which was extracted 3x with 150 ml of CH2Cl2. The combined organic phases were 
dried with Na2SO4 and the solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography, using a gradient from CH2Cl2 to CH2Cl2 / MeOH 5:1. 
The product (396 mg, 65% yield) was obtained as a slightly brownish powder which was used 
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for the next step by dissolving 104 mg (0.175 mmol) in mixture of 1 ml CH2Cl2 and 1 ml 
TFA. The removal of Boc group reaction was complete after stirring at r.t. for 2 h under N2 as 
indicated by HPLC. 25 ml of CH3CN were then added, followed by solvent removal. This 
procedure was repeated four times to produce 436 mg (72%) of 5b as a brownish solid. 
Calcd. for Mr (C12H11N2O6Re) 466.43; ESI-MS(CH3OH, pos. Mode): 467.0 [M+H]+. 1H 
NMR (500 MHz, CD3OD): δ 6.16 (m, 2H, Cp), 5.59 (t, 2H, J = 2.9 Hz, Cp), 3.75 (m, 1H, 
CH), 3.68 (m, 2H, CH2); 13C{1H} NMR (125 MHz, CD3OD): δ 194.0, 169.9 166.9, 94.5, 
88.7, 41.0. IR (KBr) 3420, 2026, 1926, 1639 cm-1 
 
5. Technetium complexes synthesis 
 
5.1. Solid phase synthesis  
NovaSyn® TG amino resin (400 mg, 0.116 mmol –NH2 groups) was left to swell in DMF 
during 1 h and washed several times with DMF. The supernatant was removed. Thiele’s acid 
(64 mg, 0.29 mmol) and O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate (HATU) (220 mg, 0.58 mmol) were dissolved in 1 ml of DMF and 
added to the resin. N,N-diisopropylethylamine (200 µl, 1.16 mmol) was added, and the 
suspension was stirred very gently for 18 h under N2 at r.t. The resin was filtered and washed 
5 x each with 5 ml of DMF, CH2Cl2, and finally 2-propanol (to de-swell the resin). The resin 
was dried in vacuo overnight and stored at 4°C prior to use. 
To check the completeness of the coupling a TNBS test was performed according to literature 
procedure [26]. No free –NH2 groups were detected, thus confirming the complete 
derivatization of the resin by Thiele’s acid. IR (KBr pellet) showed peaks at 1535 and 1712 
cm-1 not present in the unmodified resin, which were attributed to the amide bond and the 
terminal carboxylic group of Thiele’s acid, respectively. 
 
5.1. Labelling method A (one-pot labeling) 
A vial was charged with [H3BCOOH]- (4 mg) and Na2[tartrate]2H2O (7mg), Na2B4O710H2O 
(7 mg) and the ligands 4a-c. The vial was then sealed and flushed with N2. The [99mTcO4]- 
elute (1 mL) was injected into the vial and the resulting mixture was heated at 95°C for 30 
min, after which time the reaction products were analysed with HPLC coupled with gamma 
detector. 
 
5.2. Method B: 99mTc-complexes in alkaline conditions 
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To a solution of fac-[99mTc(H2O)3(CO)3]+ (1) (900 µl) 100 µl of 10-2 or 10-3 M stock solution 
of the ligands 4a-c in MeOH under N2, were added. The vials was then brought to 95°C, and 
the final solution analyzed by HPLC coupled with gamma detector after cooling to r.t. 
 
5.3. Method C: 99mTc-complexes in buffered conditions 
The pH of a solution containing 1 was adjusted (Ph = 7.4) by a solution of 1N HCl 
(respectively 1N NaOH) and phosphate buffer. 900 µl of 1 was then added to 100 µl of 10-2 or 
10-3 M stock solution of ligands 4a-c were mixed together and protected with N2. The mixture 
was allowed to heat at 95°C, and the labeling products were analyzed with HPLC coupled 
with gamma detector. 
 
5.4. Solid phase labeling of Thiele´s acid 
Polymer 7 (4 mg) was previously swelled in water at 4°C for 3h and then the solid was 
filtrated off. The vial was charged with Na[H3BCO2H] (4 mg), Na2B4O710H2O (7 mg) and 
Na2[tartrate]2H2O (7mg). The vial was then sealed and flushed with N2. The [99mTcO4]-  elute 
(1 mL) was injected into the vial and the resulting mixture was heated at 95°C for 3h, after 
which time the reaction products were analyzed with HPLC coupled with gamma detector. 
 
5.4 X-ray crystallographic data collection and refinement of the structures of dimethyl ester 
of Thiele´s acid and 5a. 
Crystallographic data were collected at 183(2) K on an Oxford Diffraction Xcalibur system 
with a Ruby detector using Mo Kα radiation (λ = 0.7107 Å) that was graphite-
monochromated. Suitable crystals were covered with oil (Infineum V8512, formerly known 
as Paratone N), mounted on top of a glass fibre and immediately transferred to the 
diffractometer. The program suite CrysAlisPro was used for data collection, semi-empirical 
absorption correction and data reduction [27]. Structures were solved with direct methods 
using SIR97[28] and were refined by full-matrix least-squares methods on F2 with SHELXL-
97 [29]. The structures were checked for higher symmetry with help of the program Platon 
[30]. Crystallographic data for the structural analysis has been deposited with the Cambridge 
Crystallographic Data Centre, CCDC No. 704728 for the dimethyl ester of Thiele’s acid and 
No. 704399 for compound 5a. 
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